1 Belot A, Grosclaude P, Bossard N, et al. (2008) Cancer incidence and mortality in France over the period 1980–2005. Revue d'Epidémiologie et de Santé Publique 56, 159–175.
2 Nelson NJ (2006) Migrant studies aid the search for factors linked to breast cancer risk. J Natl Cancer Inst 4, 436–438.
3 Puska P (2008) The North Karelia Project: 30 years successfully preventing chronic diseases. Diabetes Voice , 53, 26–29.
4 Gerber M (2009) Background review paper on total fat, fatty acid intake and cancers. Ann Nutr Metab 55, 140–161.
5 Gerber M (1996) Fiber and breast cancer: another piece of the puzzle – but still an incomplete picture. J Natl Cancer Inst 88, 857–858.
6 Smit LA, Mozaffarian D & Willett W (2009) Review of fat and fatty acid requirements and criteria for developing dietary guidelines. Ann Nutr Metab 55, 44–55.
7 World Cancer Research Fund/American Institute for Cancer Research (WCRF/AICR) (2007) Food, Nutrition, Physical Activity, and the Prevention of Cancer: A Global Perspective. Washington, DC: AICR.
8 Kato I, Majumdar AP, L J, et al. (2010) Dietary fatty acids, luminal modifiers, and risk of colorectal cancer. Int J Cancer 127, 942–951.
9 Kimura Y, Kono S, Toyomura K, et al. (2007) Meat, fish and fat intake in relation to subsite-specific risk of colorectal cancer: The Fukuoka Colorectal Cancer Study. Cancer Sci 98, 590–597.
10 Theodoratou E, McNeill G, Cetnarskyj R, et al. (2007) Dietary fatty acids and colorectal cancer: a case-control study. Am J Epidemiol 166, 181–195.
11 Kim S, Sandler DP, Galanko J, et al. (2010) Intake of polyunsaturated fatty acids and distal large bowel cancer risk in whites and African Americans. Am J Epidemiol 171, 969–979.
12 Weijenberg MP, Luchtenborg M, de Goeij AF, et al. (2007) Dietary fat and risk of colon and rectal cancer with aberrant MLH1 expression, APC or KRAS genes. Cancer Causes Control 18, 865–879.
13 Hall MN, Campos H, Li H, et al. (2007) Blood levels of long-chain polyunsaturated fatty acids, aspirin, and the risk of colorectal cancer. Cancer Epidemiol Biomarkers Prev 16, 314–321.
14 Hall MN, Chavarro JE, Lee IM, et al. (2008) A 22-year prospective study of fish, n-3 fatty acid intake, and colorectal cancer risk in men. Cancer Epidemiol Biomarkers Prev 17, 1136–1143.
15 Sasazuki S, Inoue M, Iwasaki M, et al. (2010) Prospective study group intake of n-3 and n-6 polyunsaturated fatty acids and development of colorectal cancer by subsite: Japan public health center-based prospective study. Int J Cancer .
16 Daniel CR, McCullough ML, Patel RC, et al. (2009) Dietary intake of omega-6 and omega-3 fatty acids and risk of colorectal cancer in a prospective cohort of U.S. men and women. Cancer Epidemiol Biomarkers Prev 18, 516–525.
17 Butler LM, Wang R, Koh WP, et al. (2009) Marine n-3 and saturated fatty acids in relation to risk of colorectal cancer in Singapore Chinese: a prospective study. Int J Cancer 124, 678–686.
18 Stern MC, Butler LM, Corral R, et al. (2009) Polyunsaturated fatty acids, DNA repair single nucleotide polymorphisms and colorectal cancer in the Singapore Chinese Health Study. J Nutrigenet Nutrigenomics 2, 273–279 .
19 Hoyer AP, Grandjean P, Jørgensen T, et al. (1998) Organochlorine exposure and risk of breast cancer. Lancet 352, 9143, 1816–1820.
20 Pot GK, Geelen A, van Heijningen EM, et al. (2008) Opposing associations of serum n-3 and n-6 polyunsaturated fatty acids with colorectal adenoma risk: an endoscopy-based case-control study. Int J Cancer 123, 1974–1977.
21 Gerber M, Scali J, Michaud A, et al. (2000) Profiles of a healthy diet and its relationship with biomarkers in a population sample from Mediterranean Southern France. J Amer Diet Assoc 100, 1164–1171.
22 Moreira AP, Sabarense CM, Dias CM, et al. (2009) Fish oil ingestion reduces the number of aberrant crypt foci and adenoma in 1,2-dimethylhydrazine-induced colon cancer in rats. Braz J Med Biol Res 42, 1167–1172.
23 Allred CD, Talbert DR, Southard RC, et al. (2008) PPARgamma1 as a molecular target of eicosapentaenoic acid in human colon cancer (HT-29) cells. J Nutr 138, 250–256.
24 Giros A, Grzybowski M, Sohn VR, et al. (2009) Regulation of colorectal cancer cell apoptosis by the n-3 polyunsaturated fatty acids docosahexaenoic and eicosapentaenoic. Cancer Prev Res (Phila) 2, 732–742.
25 Rogers KR, Kikawa KD, Mouradian M, et al. (2010) Docosahexaenoic acid alters epidermal growth factor receptor-related signaling by disrupting its lipid raft association. Carcinogenesis 31, 1523–1530.
26 Galli C & Calder PC (2009) Effects of fat and fatty acids intake on inflamatory and immune responses. A critical review. Ann Nutr Metab 55, 123–139.
27 Ukoli FA, Fowke JH, Akumabor P, et al. (2010) The association of plasma fatty acids with prostate cancer risk in African Americans and Africans Health. J Care Poor Underserved 21, Suppl. 1, 127–147.
28 Williams CD, Whitley BM, Hoyo C, et al. (2011) A high ratio of dietary n-6/n-3 polyunsaturated fatty acids is associated with increased risk of prostate cancer. Nutr Res 31, 1–8.
29 Fradet V, Cheng I, Casey G & Witte JS (2009) Dietary omega-3 fatty acids, cyclooxygenase-2 genetic variation, and aggressive prostate cancer risk. Clin Cancer Res 15, 2559–2566.
30 Shannon J, O'Malley J, Mori M, et al. (2010) Erythrocyte fatty acids and prostate cancer risk: a comparison of methods. Prostaglandins Leukot Essent Fatty Acids 83, 161–169.
31 Giovannucci E, Liu Y, Platz EA, et al. (2007) Risk factors for prostate cancer incidence and progression in the health professionals follow-up study. Int. J Cancer 121, 1571–1578.
32 Park SY, Murphy SP, Wilkens LR, et al. (2007) Fat and meat intake and prostate cancer risk: The multiethnic cohort study. Int. J Cancer 121, 1339–1345.
33 Wallstrom P, Bjartell A, Gullberg B, et al. (2007) A prospective study on dietary fat and incidence of prostate cancer (Malmo, Sweden). Cancer Causes Control 18, 1107–1121.
34 Chavarro JE, Stampfer MJ, Li H, et al. (2007) A prospective study of polyunsaturated fatty acid levels in blood and prostate cancer risk. Cancer Epidemiol. Biomarkers Prev 16, 1364–1370.
35 Carayol M, Grosclaude P & Delpierre C (2010) Prospective studies of dietary alpha-linolenic acid intake and prostate cancer risk: a meta-analysis. Cancer Causes Control 21, 347–355.
36 Karmali RA, Reichel P, Cohen LA, et al. (1987) The effects of dietary omega-3 fatty acids on the DU-145 transplantable human prostatic tumor. Anticancer Res 7, 1173–1179.
37 Kuriki K, Hirose K, Wakai K, et al. (2007) Breast cancer risk and erythrocyte compositions of n-3 highly unsaturated fatty acids. Japanese Int J Cancer 121, 377–385.
38 Kim J, Lim SY, Shin A, et al. (2009) Fatty fish and fish omega-3 fatty acid intakes decrease the breast cancer risk: a case-control study. BMC Cancer 30, 216–226.
39 Shannon J, King IB, Lampe JW, et al. (2009) Erythrocyte fatty acids and risk of proliferative and nonproliferative fibrocystic disease in women in Shanghai, China. Am J Clin Nutr 89, 265–276.
40 Thiébaut ACM, Chajès V, Gerber M, et al. (2008) Dietary intakes of ω-6 and ω-3 polyunsaturated fatty acids and the risk of breast cancer. Int J Cancer 124, 924–931.
41 Shannon J, King IB, Moshofsky R, et al. (2007) Erythrocyte fatty acids and breast cancer risk: a case-control study in Shanghai. China. Am J Clin Nutr 85, 1090–1097.
42 Witt PM, Christensen JH, Schmidt EB, et al. (2009) Marine n-3 polyunsaturated fatty acids in adipose tissue and breast cancer risk: a case-cohort study from Denmark. Cancer Causes Control 20, 1715–1721.
43 Brasky TM, Lampe JW, Potter JD, et al. (2010) Specialty supplements and breast cancer risk in the VITamins And Lifestyle (VITAL) Cohort. Cancer Epidemiol Biomarkers Prev 19, 1696–1708.
44 Murff HJ, Shu XO, Li H, et al. (2011) Dietary polyunsaturated fatty acids and breast cancer risk in Chinese women: a prospective cohort study. Int J Cancer 128, 1434–1441.
45 Dijkstra SC, Lampe JW, Ray RM, et al. (2010) Biomarkers of dietary exposure are associated with lower risk of breast fibroadenomas in Chinese women. J Nutr 140, 1302–1310.
46 Patterson RE, Flatt SW, Newman VA, et al. (2011) Marine fatty acid intake is associated with breast cancer prognosis. J Nutr 141, 201–206.
47 Altenburg JD & Siddiqui RA (2009) Omega-3 polyunsaturated fatty acids down-modulate CXCR4 expression and function in MDA-MB-231 breast cancer cells. Mol Cancer Res 7, 1013–1020.
48 Sun H, Berquin IM, Owens RT, et al. (2008) Peroxisome proliferator-activated receptor gamma-mediated up-regulation of syndecan-1 by n-3 fatty acids promotes apoptosis of human breast cancer cells. Cancer Res 68, 2912–2919.
49 Saadatian-Elahi M, Norat T, Goudable J, et al. (2004) Biomarkers of dietary fatty acid intake and the risk of breast cancer: a meta-analysis. Int J Cancer 111, 584–591.
50 Zuijdgeest-van Leeuwen SD, van der Heijden MS, et al. (2002) Fatty acid composition of plasma lipids in patients with pancreatic, lung and oesophageal cancer in comparison with healthy subjects. Clin Nutr 21, 225–230.
51 MacLean CH, Newberry SJ, Mojica WA, et al. (2006) Effects of omega-3 fatty acids on cancer risk: a systematic review. JAMA 295, 403–415.
52 Gong Z, Holly EA, Wang F, et al. (2010) Intake of fatty acids and antioxidants and pancreatic cancer in a large population-based case-control study in the San Francisco Bay Area. Int J Cancer 127, 1893–1904.
53 Park KS, Lim JW & Kim H (2009) Inhibitory mechanism of omega-3 fatty acids in pancreatic inflammation and apoptosis. Ann N Y Acad Sci 1171, 421–427.
54 Strouch MJ, Ding Y, Salabat MR, et al. (2011) A high omega-3 fatty acid diet mitigates murine pancreatic precancer development. J Surg Res 165, 75–81.
55 Kuriki K, Wakai K, Matsuo K, et al. (2007) Gastric cancer risk and erythrocyte composition of docosahexaenoic acid with anti-inflammatory effects. Cancer Epidemiol Biomarkers Prev 16, 2406–2415.
56 Veierød MB, Laake P & Thelle DS (1997) Dietary fat intake and risk of lung cancer: a prospective study of 51,452 Norwegian men and women. Eur J Cancer Prev 6, 540–549.
57 Lu Y, Nie D, Witt WT, et al. (2008) Expression of the fat-1 gene diminishes prostate cancer growth in vivo through enhancing apoptosis and inhibiting GSK-3 beta phosphorylation. Mol Cancer Ther 7, 3203–3211.
58 Mannini A, Kerstin N, Calorini L, et al. (2009) An enhanced apoptosis and a reduced angiogenesis are associated with the inhibition of lung colonisation in animals fed an n-3 polyunsaturated fatty acid-rich diet injected with a highly metastatic murine melanoma line. Br J Nutr 101, 688–693.
59 Lindskog M, Gleissman H, Ponthan F, et al. (2006) Neuroblastoma cell death in response to docosahexaenoic acid sensitization to chemotherapy and arsenic-induced oxidative stress. Int J Cancer 118, 2584–2593.
60 Germain E, Chajes V, Cognault S, et al. (1998) Enhancement of doxorubicin cytotoxicity by polyunsaturated fatty acids in the human breast tumor cell line MDA-MB-231: relationship to lipid peroxidation. Int J Cancer; 75, 578–583.
61 Jordan A & Stein J (2003) Effect of an omega-3 fatty acid containing lipid emulsion alone and in combination with 5-fluorouracil (5-FU) on growth of the colon cancer cell line Caco-2. Eur J Nutr 42, 324–331.
62 Cha MC, Lin A & Meckling KA (2005) Low dose docosahexaenoic acid protects normal colonic epithelial cells from araC toxicity. BM Pharmacol 5, 7–14.
63 Bougnoux P, Hajjaji N, Ferrasson MN, et al. (2009) Improving outcome of chemotherapy of metastatic breast cancer by docosahexaenoic acid: a phase II trial. Br J Cancer 101, 1978–1985.
64 Dewey A, Baughan C, Dean TP, et al. (2007) Eicosapentaneoic (EPAan oméga-3 fatty acid from fish oils) for the treatment of cancer cachexia. Cochrane database of systematic reviews .
65 Fearon KC, Barber MD, Moses AG, et al. (2006) Double-blind, placebo-controlled, randomized study of eicosapentaenoic acid diester in patients with cancer cachexia. J Clin Oncol 24, 3401–3407.
66 van der Meij BS, Langius JA, Smit EF, et al. (2010) Oral nutritional supplements containing (n-3) polyunsaturated fatty acids affect the nutritional status of patients with stage III non-small cell lung cancer during multimodality treatment. J Nutr 140, 1774–1780.
67 Murphy RA, Mourtzakis M, Chu QS, et al. (2010) Skeletal muscle depletion is associated with reduced plasma (n-3) fatty acids in non-small cell lung cancer patients. J Nutr 140, 1602–1606.
68 Murphy RA, Mourtzakis M, Chu QS, et al. (2011) Nutritional intervention with fish oil provides a benefit over standard of care for weight and skeletal muscle mass in patients with nonsmall cell lung cancer receiving chemotherapy. Cancer 117, 1775–1782.
69 Murphy RA, Mourtzakis M, Chu QS, et al. (2011) Supplementation with fish oil increases first-line chemotherapy efficacy in patients with advanced nonsmall cell lung cancer. Cancer, .
70 Hoffman R & Gerber M (2012) .